262 related articles for article (PubMed ID: 18076867)
1. Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors.
Varani K; Surprenant A; Vincenzi F; Tosi A; Gessi S; Merighi S; Borea PA
Biochem Pharmacol; 2008 Mar; 75(5):1198-208. PubMed ID: 18076867
[TBL] [Abstract][Full Text] [Related]
2. Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.
Merighi S; Simioni C; Gessi S; Varani K; Borea PA
Biochem Pharmacol; 2010 Feb; 79(3):471-7. PubMed ID: 19766600
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour.
Gessi S; Fogli E; Sacchetto V; Varani K; Merighi S; Leung E; Lennan SM; Borea PA
Biochem Pharmacol; 2008 Jan; 75(2):562-9. PubMed ID: 17936250
[TBL] [Abstract][Full Text] [Related]
4. Thermal and urea-induced unfolding of the marginally stable lac repressor DNA-binding domain: a model system for analysis of solute effects on protein processes.
Felitsky DJ; Record MT
Biochemistry; 2003 Feb; 42(7):2202-17. PubMed ID: 12590610
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes.
Varani K; De Mattei M; Vincenzi F; Tosi A; Gessi S; Merighi S; Pellati A; Masieri F; Ongaro A; Borea PA
Osteoarthritis Cartilage; 2008 Nov; 16(11):1421-9. PubMed ID: 18448363
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
Contreras ML; Wolfe BB; Molinoff PB
J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
[TBL] [Abstract][Full Text] [Related]
7. Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
Gilli P; Gilli G; Borea PA; Varani K; Scatturin A; Dalpiaz A
J Med Chem; 2005 Mar; 48(6):2026-35. PubMed ID: 15771445
[TBL] [Abstract][Full Text] [Related]
8. [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.
Jarvis MF; Bianchi B; Uchic JT; Cartmell J; Lee CH; Williams M; Faltynek C
J Pharmacol Exp Ther; 2004 Jul; 310(1):407-16. PubMed ID: 15024037
[TBL] [Abstract][Full Text] [Related]
9. Binding thermodynamics at the human A(3) adenosine receptor.
Merighi S; Varani K; Gessi S; Klotz KN; Leung E; Baraldi PG; Borea PA
Biochem Pharmacol; 2002 Jan; 63(2):157-61. PubMed ID: 11841789
[TBL] [Abstract][Full Text] [Related]
10. Binding thermodynamics of adenosine A2a receptor ligands.
Borea PA; Dalpiaz A; Varani K; Guerra L; Gilli G
Biochem Pharmacol; 1995 Feb; 49(4):461-9. PubMed ID: 7532939
[TBL] [Abstract][Full Text] [Related]
11. Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?
Borea PA; Dalpiaz A; Varani K; Gilli P; Gilli G
Biochem Pharmacol; 2000 Dec; 60(11):1549-56. PubMed ID: 11077036
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic analysis of rat brain opioid mu-receptor-ligand interaction.
Zeman P; Tóth G; Kvetnanský R
Gen Physiol Biophys; 1987 Jun; 6(3):237-48. PubMed ID: 3040520
[TBL] [Abstract][Full Text] [Related]
13. A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry.
Deinum J; Gustavsson L; Gyzander E; Kullman-Magnusson M; Edström A; Karlsson R
Anal Biochem; 2002 Jan; 300(2):152-62. PubMed ID: 11779106
[TBL] [Abstract][Full Text] [Related]
14. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor.
Wittmann HJ; Seifert R; Strasser A
Mol Pharmacol; 2009 Jul; 76(1):25-37. PubMed ID: 19346300
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic analysis does not allow discrimination of agonists and antagonists at human CCK2S-receptors.
Harper EA; Mitchell EA; Griffin EP; Kalindjian SB
Eur J Pharmacol; 2008 Feb; 581(1-2):1-12. PubMed ID: 18158148
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP
Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575
[TBL] [Abstract][Full Text] [Related]
17. Kinetic investigations of the process of encapsulation of small hydrocarbons into a cavitand-porphyrin.
Nakazawa J; Sakae Y; Aida M; Naruta Y
J Org Chem; 2007 Dec; 72(25):9448-55. PubMed ID: 17979283
[TBL] [Abstract][Full Text] [Related]
18. Hydroxylation of phenolic compounds by a peroxodicopper(II) complex: further insight into the mechanism of tyrosinase.
Palavicini S; Granata A; Monzani E; Casella L
J Am Chem Soc; 2005 Dec; 127(51):18031-6. PubMed ID: 16366554
[TBL] [Abstract][Full Text] [Related]
19. Binding thermodynamics at the human neuronal nicotine receptor.
Borea PA; Varani K; Gessi S; Gilli P; Gilli G
Biochem Pharmacol; 1998 Apr; 55(8):1189-97. PubMed ID: 9719473
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamic descriptors, profiles and driving forces in membrane receptor-ligand interactions.
Pliska V
J Recept Signal Transduct Res; 2010 Dec; 30(6):454-68. PubMed ID: 20923252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
